WORK Medical Technology (WOK) Common Equity (2023 - 2025)

WORK Medical Technology has reported Common Equity for 3 years, with the latest figure at $18.3 million in Q3 2025.

• For the quarter ending Q3 2025, Common Equity rose 14.12% year-over-year to $18.3 million; the trailing twelve-month figure through Sep 2025 stood at $18.3 million (up 14.12% YoY), and the FY2025 full-year result was $18.3 million, up 14.12% from the prior year.
• Common Equity for Q3 2025 stood at $18.3 million, up from $12.9 million in the prior quarter.
• The five-year high for Common Equity was $18.3 million in Q3 2025, with the low at $11.0 million in Q3 2023.
• Historically, Common Equity has averaged $14.6 million across 3 years, with a median of $14.5 million in 2024.
• Annual changes were most pronounced in 2024 — Common Equity jumped 46.28% — and 2025, when it increased 14.12%.
• WORK Medical Technology's Common Equity stood at $11.0 million in 2023, then surged by 46.28% to $16.1 million in 2024, then advanced by 14.12% to $18.3 million in 2025.
• The last three Common Equity figures came in at $18.3 million (Q3 2025), $12.9 million (Q1 2025), and $16.1 million (Q3 2024), per Business Quant data.